Mostrar el registro sencillo del ítem
Artículo
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
dc.creator | García Revilla, Juan | es |
dc.creator | Deierborg, Tomas | es |
dc.creator | Venero Recio, José Luis | es |
dc.creator | Boza Serrano, Antonio | es |
dc.date.accessioned | 2021-08-05T09:27:57Z | |
dc.date.available | 2021-08-05T09:27:57Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | García Revilla, J., Deierborg, T., Venero Recio, J.L. y Boza Serrano, A. (2020). Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider. Frontiers In Immunology, 11, 2069. | |
dc.identifier.issn | 1664-3224 (electrónico) | es |
dc.identifier.uri | https://hdl.handle.net/11441/116610 | |
dc.description.abstract | COVID-19 disease have become so far the most important sanitary crisis in the XXI century. In light of the events, any clinical resource should be considered to alleviate this crisis. Severe COVID-19 cases present a so-called cytokine storm as the most life-threatening symptom accompanied by lung fibrosis. Galectin-3 has been widely described as regulator of both processes. Hereby, we present compelling evidences on the potential role of galectin-3 in COVID-19 in the regulation of the inflammatory response, fibrosis and infection progression. Moreover, we provide a strong rationale of the utility of measuring plasma galectin-3 as a prognosis biomarker for COVID-19 patients and propose that inhibition of galectin-3 represents a feasible and promising new therapeutical approach. | es |
dc.format | application/pdf | es |
dc.format.extent | 6 p. | es |
dc.language.iso | eng | es |
dc.publisher | Frontiers Media | es |
dc.relation.ispartof | Frontiers In Immunology, 11, 2069. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | COVID-19 | es |
dc.subject | Cytokine storm | es |
dc.subject | Fibrosis | es |
dc.subject | Galectin-3 | es |
dc.subject | Biomarker | es |
dc.title | Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular | es |
dc.relation.publisherversion | https://doi.org/10.3389/fimmu.2020.02069 | es |
dc.identifier.doi | 10.3389/fimmu.2020.02069 | es |
dc.journaltitle | Frontiers In Immunology | es |
dc.publication.volumen | 11 | es |
dc.publication.initialPage | 2069 | es |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Hyperinflammation.pdf | 691.2Kb | [PDF] | Ver/ | |